pharmaphorum5d
GSK says new inhaler will help slash its carbon footprint
The technology is ready to start phase 3 testing in GSK’s asthma product Ventolin (salbutamol) next year, and according to the drugmaker has the potential to reduce greenhouse gas emissions from ...
New York Post6d
FDA greenlights GSK’s drug for UTIs in women and girls
The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...
Yahoo Finance4d
Jim Cramer Says ‘Buy and Put Away’ GSK (GSK) for Its 4% Yield
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other stocks that Jim Cramer discussed. On Tuesday, Jim Cramer, host of Mad Money, defended the growing wave ...
Bloomberg L.P.4d
GSK Wants UK to Open Up Health Records to Boost Drug Development
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to accelerate drug development and halt the nation’s slide down global life ...
pharmaphorum1d
GSK says $2.2bn settlement resolves most Zantac litigation
GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...
Medscape6d
Single-Dose Intravenous Salbutamol Bolus for Managing Children With Acute Severe Asthma in the Emergency Department: Reanalysis of Data
Objective: To reanalyze data from two previous studies to provide stronger evidence of benefit for early use of single-dose intravenous bolus salbutamol in children with acute severe exacerbations ...
Business Today4d
Glaxosmithkline Pharmaceuticals Ltd (GLAXO) Share Price
Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...